InvestSMART

Bio-Gene Technology Ltd (ASX:BGT)

ALERT: Price-sensitive ASX Announcement for BGT
Current share price for BGT : $0.014 -0.024 (-63.16%)+
Announcement
Release
27 Apr 2026 11:55AM
Price at Release
$0.038
Full Release
download
Summary
Bio-Gene Technology Limited reported on its activities for the quarter ending March 31, 2026. The company is progressing with its Flavocide® regulatory program, including ongoing studies such as the rat acute neurotoxicity and reproductive toxicity studies. Bio-Gene aims to submit its first registration to the Australian Pesticides & Veterinary Medicines Authority (APVMA) by March 2027. Additionally, Bio-Gene has signed a non-binding term sheet with Sumitomo Corporation and Nakashima Trading Co. to develop and market Qcide® insecticide products in Japan by late 2026. The company also completed its 15th harvest of Qcide oil in Queensland. Cash flow activities indicate a decrease in operating cash flow, with cash and cash equivalents at the end of the quarter at AUD 674,000.
Key Points
  • Bio-Gene is developing novel insecticides derived from nature.
  • Flavocide studies are progressing, targeting first APVMA submission in March 2027.
  • Non-binding term sheet with Sumitomo and Nakashima for Qcide in Japan.
  • Completed 15th Qcide harvest in Queensland.
  • Operating cash flow resulted in a net cash decrease.
  • Cash and cash equivalents were AUD 674,000 at quarter end.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.